Abstract
The discovery of anandamide as an endogenous ligand for the cannabinoid receptors has led to a resurgence of interest in the fatty acid amides. However, N-palmitoylethanolamine (PEA), a shorter and fully saturated analogue of anandamide, has been known since the fifties. This endogenous compound is a member of the N-acylethanolamines, found in most mammalian tissues. PEA is accumulated during inflam-mation and has been demonstrated to have a number of anti-inflammatory effects, including beneficial effects in clinically relevant animal models of inflammatory pain. It is now engaged in phase II clinical development, and two studies regarding the treatment of chronic lumbosciatalgia and multiple sclerosis are in progress. However, its precise mechanism of action remains debated. In the present review, the biochemical and pharmacological properties of PEA are discussed, in particular with respect to its analgesic and anti-inflammatory properties.
Keywords: Palmitoylethanolamide, anandamide, cannabinoid, N-acylethanolamines, dicyclohexylcarbodiimide, N-palmitoylethanolamine, N-oleoylethanolamine, Tetrahydrocannabinol, Amide Hydrolase
Current Medicinal Chemistry
Title: The Palmitoylethanolamide Family: A New Class of Anti-Inflammatory Agents ?
Volume: 9 Issue: 6
Author(s): Didier M. Lambert, Severine Vandevoorde, Kent-Olov Jonsson and Christopher J. Fowler
Affiliation:
Keywords: Palmitoylethanolamide, anandamide, cannabinoid, N-acylethanolamines, dicyclohexylcarbodiimide, N-palmitoylethanolamine, N-oleoylethanolamine, Tetrahydrocannabinol, Amide Hydrolase
Abstract: The discovery of anandamide as an endogenous ligand for the cannabinoid receptors has led to a resurgence of interest in the fatty acid amides. However, N-palmitoylethanolamine (PEA), a shorter and fully saturated analogue of anandamide, has been known since the fifties. This endogenous compound is a member of the N-acylethanolamines, found in most mammalian tissues. PEA is accumulated during inflam-mation and has been demonstrated to have a number of anti-inflammatory effects, including beneficial effects in clinically relevant animal models of inflammatory pain. It is now engaged in phase II clinical development, and two studies regarding the treatment of chronic lumbosciatalgia and multiple sclerosis are in progress. However, its precise mechanism of action remains debated. In the present review, the biochemical and pharmacological properties of PEA are discussed, in particular with respect to its analgesic and anti-inflammatory properties.
Export Options
About this article
Cite this article as:
Lambert M. Didier, Vandevoorde Severine, Jonsson Kent-Olov and Fowler J. Christopher, The Palmitoylethanolamide Family: A New Class of Anti-Inflammatory Agents ?, Current Medicinal Chemistry 2002; 9 (6) . https://dx.doi.org/10.2174/0929867023370707
DOI https://dx.doi.org/10.2174/0929867023370707 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Release of Adenosine and ATP During Ischemia and Epilepsy
Current Neuropharmacology Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Cerebral Inflow and Outflow Discrepancies in Severe Sudden Sensorineural Hearing Loss
Current Neurovascular Research Methionine-Independent Translation Initiation from Naturally Occurring Non-AUG Codons
Current Chemical Biology Dietary Fat Intake and Risk of Alzheimer’s Disease and Dementia: A Meta-Analysis of Cohort Studies
Current Alzheimer Research Salivary Antioxidant and Oxidative Stress Marker Levels in HIV-Positive Individuals
Combinatorial Chemistry & High Throughput Screening In Silico ADME and QSAR Studies on a Set of Coumarin Derivatives As Acetylcholinesterase Inhibitors Against Alzheimer’s Disease: CoMFA, CoMSIA, Topomer CoMFA, and HQSAR
Letters in Drug Design & Discovery The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
Mini-Reviews in Medicinal Chemistry Classification of Peptides According to their Blood-Brain Barrier Influx
Protein & Peptide Letters Autoimmune Hepatitis: Pathophysiology, Diagnosis and Pharmacological Therapy
Current Immunology Reviews (Discontinued) Drug Withdrawal and Hyperphagia: Lessons from Tobacco and Other Drugs
Current Pharmaceutical Design Evidence for Altered LRP/RAGE Expression in Alzheimer Lesion Pathogenesis
Current Alzheimer Research Meet Our Editorial Board Member
Combinatorial Chemistry & High Throughput Screening Th17 Cells in Airway Diseases
Current Molecular Medicine The Role of Platelet/Lymphocyte Serotonin Transporter in Depression and Beyond
Current Drug Targets New Trends in Thromboxane and Prostacyclin Modulators
Current Medicinal Chemistry Recent Advances in Computational Studies on Influenza A Virus M2 Proton Channel
Mini-Reviews in Medicinal Chemistry Lipid Rafts Mediate Amyloid-Induced Calcium Dyshomeostasis and Oxidative Stress in Alzheimer’s Disease
Current Alzheimer Research Molecule of the Month
Current Topics in Medicinal Chemistry Nitric Oxide Control of Proliferation in Nerve Cells and in Tumor Cells of Nervous Origin
Current Pharmaceutical Design